ExploreQC: A toolbox for MRI quality control in the EPAD multicentre study
Luigi Lorenzini(Amsterdam Neuroscience), Henk Mutsaerts(Amsterdam Neuroscience), José Luís Molinuevo(Pasqual Maragall Foundation), Joost P.A. Kuijer(Amsterdam UMC Location VUmc), David M. Cash(UK Dementia Research Institute), Carole H. Sudre(King's College London), Sven Haller(Ulsan College), Adam Waldman(Royal Society of Edinburgh), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Juan Domingo Gispert(Lund University), Sjoerd B. Vos(Laboratoire d’Imagerie Biomédicale), Alle Meije Wink(University of Cambridge), Jan Petr(Helmholtz-Zentrum Dresden-Rossendorf), Silvia Ingala(Amsterdam UMC Location Vrije Universiteit Amsterdam), Cyril Pernet(University of Edinburgh), David L. Thomas(University College London), Robin Wolz(Ixico (United Kingdom)), Viktor Wottschel(University of Geneva)
Cited by 1
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k